VolitionRx Limited Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
VolitionRx Limited (VNRX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 5.34 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13
- VolitionRx Limited antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 3.85M shares.
- VolitionRx Limited antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2020-03-31 was 4.33M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month |
|---|---|---|---|
| 2026-06-30 | 5.34M shares 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | 3.85M shares 10-Q · filed 2026-05-14 | ||
| 2020-09-30 | 4.55M shares 10-Q · filed 2020-11-12 | ||
| 2020-06-30 | 5.21M shares 10-Q · filed 2020-08-13 | ||
| 2020-03-31 | 4.33M shares 10-Q · filed 2020-05-07 | ||
| 2019-09-30 | 4.41M shares 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |